Ep. 133: Nina Deka: Healthcare Technology Still In Early Stages Of Disruption
Investing With IBD
00:00
Using Cattle to Get a Drug to Market
Companies like cattlet get paid for helping a company with their clinical trial. If that drug never comes to market, if it fails, cattlean still did the business. They's still rigt. And then decades later, when when the drugs fall off patent, guess who still hold the ability to manufacture this thing at scale? A and so as generics come into play, they might ring catheline's, cataline's phone number and say, hey, we we understand.
Transcript
Play full episode
